Brand Name: FABHALTA Generic Name: (iptacopan)
FABHALTA (iptacopan) is used to treat paroxysmal nocturnal hemoglobinuria
Fabhalta is a medicine used in adults with paroxysmal nocturnal haemoglobinuria (PNH) to treat haemolytic anaemia. PNH is rare, and Fabhalta was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 4 June 2020.
Fabhalta contains the active substance iptacopan.
Brand Name: | FABHALTA |
Generic Name: | iptacopan |
Strength: | Capsules: 200 mg |
Manufacturer: | Novartis Pharmaceuticals Corporation |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “FABHALTA(iptacopan)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for FABHALTA(iptacopan) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.